BSc (Hons) PhD
Project Manager / Research Coordinator
In addition, Marco assists Professor MacLaren in the management of his world-class research group, which has established itself as an international leader in the use of gene therapy, electronic retinas ('bionic eyes') and robotic surgery for the treatment of retinal diseases, which includes coordinating the £1.6 million REGENERATE (REP1 Gene Replacement Therapy) study, which is a multicentre Phase 2 clinical trial of a gene therapy for choroideremia.
Marco's role in business development includes sourcing of new avenues of funding from governmental agencies, research foundations and charitable organisations, as well as exploring potential collaborative partnerships with biopharmaceutical companies and other industrial partners.
Bellini MP. and Manchester KL., (1999), Anal Biochem, 268, 21 - 29
Bellini MP. and Manchester KL., (1998), Electrophoresis, 19, 1590 - 1595